Rchr
J-GLOBAL ID：201801002651458979
Update date: Oct. 02, 2024
Nakamura Hideaki
Nakamura Hideaki
Affiliation and department：
Research field (4)：
Genomics
, Tumor biology
, Tumor diagnostics and therapeutics
, Hematology and oncology
Research keywords (5)：
がんゲノム医療
, Transcriptional regulation
, Hypoxia
, HTLV-1
, Adult T-cell Leukemia/Lymphoma
Research theme for competitive and other funds (3)：
- 2023 - 2025 Establishment of a risk assessment method for progression to aggressive type adult T-cell leukemia/lymphoma using clonality analysis.
- 2020 - 2023 マルチプレックスRT-PCR法による成人T細胞白血病の病期進展リスク評価法の開発
- 2018 - 2021 Construction of cfDNA quality management and quality check system in genetic testing
Papers (22)：
-
Marie Yamada, Mami Nakao, Naotomo Yamada, Hideaki Nakamura, Manabu Itoh, Junji Yunoki, Keiji Kamohara, Shinya Kimura, Eisaburo Sueoka. Immune cell kinetics after allogeneic red blood cell transfusion in patients undergoing cardiovascular surgery. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 2024
-
Yasushi Kubota, Haruhiko Sano, Yuji Takeda, Kyosuke Yamaguchi, Hideaki Nakamura, Keita Kai, Keisuke Kidoguchi, Kana Kusaba, Masako Yokoo, Toshihiko Ando, et al. Pure Red Cell Aplasia in a Patient with Thymic Hyperplasia, Hypogammaglobulinemia and Adult T-cell Leukemia/Lymphoma. Internal medicine (Tokyo, Japan). 2024
-
Tatsuro Watanabe, Yuta Yamamoto, Yuki Kurahashi, Kazunori Kawazoe, Keisuke Kidoguchi, Hiroshi Ureshino, Kazuharu Kamachi, Nao Yoshida-Sakai, Yuki Fukuda-Kurahashi, Hideaki Nakamura, et al. Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells. Blood advances. 2024
-
Hiroo Katsuya, Hideaki Nakamura, Aya Maeda, Keitaro Ishii, Toshiaki Nagaie, Haruhiko Sano, Haruna Sano, Hidekazu Itamura, Sho Okamoto, Toshihiko Ando, et al. HTLV-1 cell-free DNA in plasma as a potential biomarker in HTLV-1 carriers and adult T-cell leukemia-lymphoma. eJHaem. 2023
-
Yohei Harada, Akemi Sato, Hideaki Nakamura, Keita Kai, Sho Kitamura, Tomomi Nakamura, Yuki Kurihara, Sadakatsu Ikeda, Eisaburo Sueoka, Shinya Kimura, et al. Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer. BMC Cancer. 2023. 23. 1
ｍore...
MISC (1)：
-
末岡 榮三朗, 佐藤 明美, 中村 秀明, 藤井 進. 【医療情報が紡ぐ『いのち・ヒト・夢』】(いのち)医療情報が救ういのち-リアルワールドデータからプレシジョンメディシンへ- ビッグデータと個人を繋ぐ基盤整備. 医療情報学. 2018. 38. 1. 27-27
Lectures and oral presentations (15)：
-
成人T細胞白血病/リンパ腫細胞におけるDNAとヒストンのメチル化異常を標的とした併用療法
(日本血液学会学術集会 2023)
-
成人T細胞白血病/リンパ腫細胞の増殖を支えるピリミジンヌクレオチド代謝変換(Fine-tuning pyrimidine biosynthesis supports vigorous proliferation in leukemogenesis of adult T-cell leukemia/lymphoma)
(日本癌学会総会記事 2023)
-
当院で作製した看護師用輸血教育動画の活用について
(日本輸血細胞治療学会誌 2023)
-
日本赤十字血液センターから当院への遡及調査依頼について
(日本輸血細胞治療学会誌 2023)
-
赤血球製剤輸血後に献血者の新型コロナウイルス感染が判明した1症例
(日本輸血細胞治療学会誌 2023)
ｍore...
Education (2)：
- 2004 - 2008 Hiroshima University
- 1996 - 2002 Hiroshima University School of Dentistry
Professional career (1)：
Work history (5)：
- 2016/01 - 現在 Saga University Hospital
- 2015/11 - 2015/12 Saga University
- 2009/01 - 2015/10 Karolinska Institutet Cell and Molecular Biology Postdoctoral fellow & Senior lab manager
- 2005/04 - 2008/12 Hiroshima University
- 2002/06 - 2004/03 Hiroshima University Faculty of Dentistry
Association Membership(s) (6)：
The Japan Society of Transfusion Medicine and Cell Therapy
, The Japanese Association Cancer and Hypoxia research
, 日本HTLV-1学会
, THE JAPANESE CANCER ASSOCIATION
, 日本人類遺伝学会
, 日本遺伝子診療学会
